Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan

Nylon Bristles and Elastomers Retain Centigram Levels of Triclosan and Other Chemicals from Toothpastes: Accumulation and Uncontrolled Release

(2017) Jie Han et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice

(2015) Sebastian A. Mikolajczak et al.   Cell Host & Microbe

Understanding artemisinin-resistant malaria

(2015) Rick M. Fairhurst   CURRENT OPINION IN INFECTIOUS DISEASES

Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases

(2015) K. Williams et al.   Journal of the Royal Society Interface

A novel multiple-stage antimalarial agent that inhibits protein synthesis

(2015) Beatriz Baragaña et al.   NATURE

Genetic architecture of artemisinin-resistant Plasmodium falciparum

(2015) Olivo Miotto et al.   NATURE GENETICS

Malaria medicines: a glass half full?

(2015) Timothy N. C. Wells et al.   NATURE REVIEWS DRUG DISCOVERY

Prioritization of active antimalarials using structural interaction profile ofPlasmodium falciparumenoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives

(2015) S.P. Kumar et al.   SAR AND QSAR IN ENVIRONMENTAL RESEARCH

Profiling the host response to malaria vaccination and malaria challenge

(2015) Susanna Dunachie et al.   VACCINE

Identification and Deconvolution of Cross-Resistance Signals from Antimalarial Compounds Using Multidrug-Resistant Plasmodium falciparum Strains

(2014) Monika Chugh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression Levels of pvcrt-o and pvmdr-1 Are Associated with Chloroquine Resistance and Severe Plasmodium vivax Malaria in Patients of the Brazilian Amazon

(2014) Gisely C. Melo et al.   PLoS One

Spatial distribution of G6PD deficiency variants across malaria-endemic regions

(2013) Rosalind E Howes et al.   MALARIA JOURNAL

Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds

(2013) E. Bilsland et al.   Open Biology

Novel diaryl ureas with efficacy in a mouse model of malaria

(2012) John W. Anderson et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Analysis of subtelomeric virulence gene families inPlasmodium falciparumby comparative transcriptional profiling

(2012) Kathrin Witmer et al.   MOLECULAR MICROBIOLOGY

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

(2012) Y. Yuthavong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors

(2011) Xin Zhang et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Triclosan is minimally effective in rodent malaria models

(2011) Werner Baschong et al.   NATURE MEDICINE

Functional Expression of Parasite Drug Targets and Their Human Orthologs in Yeast

(2011) Elizabeth Bilsland et al.   PLoS Neglected Tropical Diseases

Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase

(2009) Vladimir Frecer et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Triclosan inhibit the growth of the late liver-stage ofPlasmodium

(2009) Agam Prasad Singh et al.   IUBMB LIFE

The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites

(2008) Min Yu et al.   Cell Host & Microbe

Type II fatty acid synthesis is essential only for malaria parasite late liver stage development

(2008) Ashley M. Vaughan et al.   CELLULAR MICROBIOLOGY

A New Purple Fluorescent Color Marker for Genetic Studies in Saccharomyces cerevisiae and Candida albicans

(2008) S. Keppler-Ross et al.   GENETICS

Network pharmacology: the next paradigm in drug discovery

(2008) Andrew L Hopkins   Nature Chemical Biology